Phase 1 trial of a 24-valent Klebsiella capsular polysaccharide vaccine and an eight-valent Pseudomonas O-polysaccharide conjugate vaccine administered simultaneously
- 1 January 1994
- Vol. 12 (14), 1288-1294
- https://doi.org/10.1016/s0264-410x(94)80054-4
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- The Efficacy of Combination Immunotherapy in Experimental Pseudomonas SepsisThe Journal of Infectious Diseases, 1993
- Affinity Constants of Naturally Acquired and Vaccine-Induced Anti-Pseudomonas aeruginosa Antibodies in Healthy Adults and Cystic Fibrosis PatientsThe Journal of Infectious Diseases, 1992
- Safety and immunogenicity of Pseudomonas aeruginosa conjugate A vaccine in cystic fibrosisThe Lancet, 1991
- Production and Characterization of a Human Hyperimmune Intravenous Immunoglobulin against Pseudomonas aeruginosa and Klebsiella SpeciesThe Journal of Infectious Diseases, 1991
- Patients with IgG subclass and/or selective antibody deficiency to polysaccharide antigens: Initiation of a controlled clinical trial of intravenous immune globulinJournal of Allergy and Clinical Immunology, 1989
- Protective activity of an intravenous immune globulin (human) enriched in antibody against lipopolysaccharide antigens of Pseudomonas aeruginosaThe American Journal of Medicine, 1984
- Progress in immunization againstKlebsiella infectionsEuropean Journal of Clinical Microbiology & Infectious Diseases, 1983
- The Clinical Significance of Positive Blood Cultures: A Comprehensive Analysis of 500 Episodes of Bacteremia and Fungemia in Adults. II. Clinical Observations, with Special Reference to Factors Influencing PrognosisClinical Infectious Diseases, 1983
- Gram-negative bacteremiaThe American Journal of Medicine, 1980
- Protective activity of antibodies to exotoxin A and lipopolysaccharide at the onset of Pseudomonas aeruginosa septicemia in man.Journal of Clinical Investigation, 1979